Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.

导出 LinkOut

翻译打印收藏纠错

作者： Ae-Young,Her ^[1] ; Byoung Geol,Choi ^[2] ; Seung-Woon,Rha ^[3] ; Yong Hoon,Kim ^[1] ; Myung Ho,Jeong ^[4] ; Korea Acute Myocardial Infarction Registry (KAMIR)-National Institutes of Health (NIH) investigators

作者单位： Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea. ^[1] Cardiovascular Research Institute, Korea University, Seoul, South Korea. ^[2] Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea. ^[3] The Heart Center of Chonnam National University Hospital, Gwangju, South Korea. ^[4]

关键词 Metformin (MET)acute myocardial infarction (AMI)dipeptidyl peptidase-4 inhibitors (DPP4i)sulfonylureas (SU)type 2 diabetes mellitus (type 2 DM)

DOI 10.21037/cdt-23-349

PMID 38434553

发布时间 2024-03-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cardiovascular diagnosis and therapy

2024年14卷1期

38-50页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.

Cardiovascular diagnosis and therapy

相似文献

Cardiovascular diagnosis and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.

Cardiovascular diagnosis and therapy

相似文献

Cardiovascular diagnosis and therapy

相关期刊

检索历史清除